I'm not recommending that anyone try this, but the morning after pill (mifepristone) is supposed to reset the HPA axis by antagonizing glucocorticoid receptors. Glucocorticoids are implicated in extreme chronic stress-induced neurotoxicity to hippocampal neurons.
Serotonin is one of the main actors in Cortisol release.
So if Your HPA axis is deregulated, it might be due to Serotonin, besides the several mechanism where Cortisol reinforces him self via e.g. increased expression of FKBP 5 by cortisol
because FKBP5 decreases Glucocorticoid receptor expression and leads to a decreased negative feedback of Glucocrticoids; thus an increase :
Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in healthy adults.
http://www.ncbi.nlm....pubmed/23274505
Heres a little overview of the implication of some Serotonin receptors:
(The 5-ht2C and its implication in anxiety and/or fear is obvious, so I dont mention it)
Effect of a series of 5-HT4 receptor agonists and antagonists on steroid secretion by the adrenal gland in vitro
http://www.researchg..._gland_in_vitro
Lysine is a partial 5-ht4 antagonist:
L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats.
http://www.ncbi.nlm....pubmed/14676321
The picture is indeed more complicated, even if You stay in the Serotonin system and look at e.g. the 5-ht2b receptor:
Activation of 5-HT2B Receptors in the Medial Amygdala causes Anxiolysis in the Social Interaction Test in the Rat
http://www.sciencedi...028390897000427
5-HT2 ligands in the treatment of anxiety and depression
Because anxiety is a comorbid illness usually observed indepressed patients after acute administration of SSRIs,
the beneficial effects of 5-HT2A and 5-HT2C receptor antagonists or 5-HT2B receptor agonists on the antidepressant response could involve anxiolytic activities
http://www.neurophar...es/22917059.pdf
Leads to a release of Serotonine and Dopamine via activaton of the VTA and Raphe:
Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice
http://journals.plos...al.pone.0007952
The problem here is that 5-ht2B activation leads to heart valve damages(or something like that) when taken over a longer period:
Drug-induced Valvulopathy: An Update
http://tpx.sagepub.c...t/38/6/837.full
AND
leads to an increase of arterial wall thickening which occurs in Users who take serotonine increasing Antidepressants.
You might think that this thickening is good, but it actually decreases the elasticity of the vessels and leads therefore to hypertension and if I remember correctly (no guarantee!)
to an increase of hermorhages/bleeding
Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension
..recent studies confirmed that other 5-HT2B antagonists (terguride, PRX-08066, or C-122) significantly reduced pulmonary pressure, arterial wall thickening, and lumen occlusion but maintained cardiac function
http://www.bloodjour...so-checked=true
Btw: PPAR Y activation could decrease the expression of 5-ht2B and perhaps the thickening(?)
Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
http://www.ncbi.nlm....pubmed/23108648
or the 5-ht7:
The 5-HT7 receptor: A key mechanism of endocrine dysregulation in stress-related disorders?
...Interestingly, pharmacological blockade of 5-HT7 receptors normalized
increased acute stress-induced corticosterone secretion in chronically stressed animals.
http://omicsonline.o....S1.005-030.pdf
Edited by Flex, 05 May 2015 - 04:02 PM.